Bharat Biotech, SII approach DCGI for using Covid vaccine on those using blood thinners: ICMR DG

By: |
January 28, 2021 9:05 PM

Responding to a query during a press conference, ICMR chief Balram Bhargava clarified that there is no contraindication in administering COVID-19 vaccines to those who are on blood thinners such as aspirin and clopidogrel.

Covid-19 vaccineBeneficiaries will have to register themselves by downloading the Co-win app 2.0.

ICMR chief Balram Bhargava on Thursday said COVID-19 vaccine manufacturers–Bharat Biotech and Serum Institute–have approached the country’s drugs regulator to make changes in the fact sheet to permit the use of the vaccine on people using blood thinners.

Responding to a query during a press conference, he clarified that there is no contraindication in administering COVID-19 vaccines to those who are on blood thinners such as aspirin and clopidogrel.

The relative contraindication regarding blood thinners is mentioned in the fact sheet of both the vaccines, Covaxin and Covishield, he said.

“Both the companies have written to the DCGI regarding changing this point and that will happen very soon,” Bhargava said.

Oxford COVID-19 vaccine ‘Covishield’ manufactured by the Serum Institute of India (SII) and indigenously developed ‘Covaxin’ of Bharat Biotech have been approved by the Drugs Controller General of India (DCGI) for restricted emergency use in the country.

Elaborating further, the ICMR Director General said there are two categories of blood thinners. The first one is ‘antiplatelets’ such as aspirin and clopidogrel, which is not a problem at all, he said.

“The second category is anticoagulants like heparan, and these patients have a tendency to bleed much higher. The only worry is, there can be local hematoma or swelling can occur where the injection site is. Therefore, it is a very relative contraindication. The anticoagulants can be stopped for one or two days before giving the vaccine.

“But as for blood thinners like aspirin and clopidogrel, there is no contraindication and that will be corrected in the fact sheet as soon as the drugs controller will give permission for the same,” Bhargava added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
167.6 pc population above 6 years found to have Covid antibodies in 4th national serosurvey, Lok Sabha told
2Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme
3Over 2.75 crore unutilised vaccine doses still available with states, private hospitals: Govt